FDA committee proposes overhaul of perioperative lung cancer trials
The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.
Cancer
ExThera’s device reduces spread of pancreatic cancer cells
Pangea’s AI imaging platform predicts cancer treatment response
Regeneron touts success with bispecific antibody in multiple myeloma trial
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
ASCO24: Precede Biosciences assay classifies HER2 and ER status in cancers
FDA ratifies CEL-SCI’s confirmatory study plan for head and neck cancer therapy
Prothea debuts with $13m to develop cancer diagnostics and treatment
